Adamax 10mg 10vials

Description

ADMAX >99% Purity | Synergistic Repair Complex

Product Specifications

• Components: BPC-157 (CAS 137525-51-0), TB-500 (CAS 77591-33-4)
• Molecular Weight: BPC: 1419.5 Da | TB-500: 4963.5 Da
• Purity: >99.0% via HPLC-UV and Mass Spectrometry
• Appearance: Sterile white lyophilized cake

How It Works

The biochemical activity of ADMAX relies on the complementary kinetics of its constituents. Initially, the BPC-157 moiety up-regulates VEGFR2 expression in vascular endothelial cells. This defines the first semantic triple: [ADMAX induces angiogenesis]. Following this, the TB-500 component binds to G-actin monomers, promoting cellular migration and wound contraction. This establishes the second triple: [ADMAX facilitates actin polymerization]. Finally, the formulation modulates the activity of Focal Adhesion Kinase (FAK), accelerating the recruitment of fibroblasts to the injury site. This forms the third triple: [ADMAX stimulates fibroblast migration]. Quantitatively, BPC-157 maintains biological stability for >4 hours in extreme environments, while TB-500 exhibits a systemic half-life of ~1.8 hours. Unlike GHK-Cu, which relies on copper-ion cross-linking for collagen maturation, ADMAX focuses on the direct up-regulation of growth factors and cytoskeletal restructuring.

Compound Background

ADMAX is a specialized dual-peptide matrix combining BPC-157 (Body Protective Compound) and TB-500 (Thymosin Beta-4 fragment) to maximize regenerative signaling within musculoskeletal tissues. This complex addresses both structural repair and cellular motility to support tissue homeostasis. The formulation is specifically designed for high-fidelity research into accelerated wound closure and extracellular matrix (ECM) remodeling.

Experimental Outcomes

• Accelerated Tendon and Ligament Repair: Users report faster recovery from chronic strains and acute tears through enhanced collagen deposition.
• Localized Inflammation Resolution: Study data demonstrates a marked reduction in localized swelling and pro-inflammatory cytokine markers.
• Enhanced Gastric Mucosal Integrity: As documented in protocols, the BPC-157 component supports the repair of the gastrointestinal lining.
• Improved Range of Motion: Cross-study analysis suggests that reduced scar tissue formation leads to better joint mobility post-injury.
• Neural Protection: Research models have observed potential neuro-regenerative effects following peripheral nerve trauma.

Summary:
ADMAX represents a high-feasibility research tool for investigating the synergy between angiogenic signaling and actin-mediated cellular repair.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.